A Biotech Company spun out of professor Tommy Anderssons research at Lund University, Sweden
The focus and aim of WntResearch is to develop novel anti-metastatic therapies.
Foxy-5 in Clinical Phase 1
Development of a small peptide, Foxy-5, mimicking the effects of Wnt-5a
Foxy-5 - Preliminary Report: Phase I
Dose Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of Foxy-5